Retinal thickness in healthy and diabetic subjects measured using optical coherence tomography mapping software.

PubWeight™: 2.02‹?› | Rank: Top 2%

🔗 View Article (PMID 12022281)

Published in Eur J Ophthalmol on May 22, 2002

Authors

P Massin1, A Erginay, B Haouchine, A Ben Mehidi, M Paques, A Gaudric

Author Affiliations

1: Department of Ophthalmology, Hĵpital Lariboisière, Assistance Publique - Hĵpitaux de Paris, Université Paris 7, France. p.massin@lrb.ap-hop-paris.fr

Articles citing this

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol (2009) 3.99

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol (2009) 3.46

Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography. Arch Ophthalmol (2006) 3.13

Spectral-domain optical coherence tomography in subjects over 60 years of age, and its implications for designing clinical trials. Br J Ophthalmol (2012) 2.03

Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. Am J Ophthalmol (2008) 1.87

Retinal thickness analysis by race, gender, and age using Stratus OCT. Am J Ophthalmol (2009) 1.86

The effect of acute hyperglycemia on retinal thickness and ocular refraction in healthy subjects. Graefes Arch Clin Exp Ophthalmol (2008) 1.67

Decreased optical coherence tomography-measured pericentral retinal thickness in patients with diabetes mellitus type 1 with minimal diabetic retinopathy. Br J Ophthalmol (2007) 1.48

Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. Invest Ophthalmol Vis Sci (2008) 1.36

"Light" versus "classic" laser treatment for clinically significant diabetic macular oedema. Br J Ophthalmol (2005) 1.21

Retinal thickness in people with diabetes and minimal or no diabetic retinopathy: Heidelberg Spectralis optical coherence tomography. Invest Ophthalmol Vis Sci (2012) 1.17

Comparison of optical coherence tomography models OCT1 and Stratus OCT for macular retinal thickness measurement. Br J Ophthalmol (2005) 1.14

Macular edema and visual outcome following cataract surgery in patients with diabetic retinopathy and controls. Graefes Arch Clin Exp Ophthalmol (2010) 1.06

Normative database of retinal nerve fiber layer and macular retinal thickness in a Thai population. Jpn J Ophthalmol (2008) 1.05

Selective retina therapy (SRT) for clinically significant diabetic macular edema. Graefes Arch Clin Exp Ophthalmol (2010) 1.00

Comparison of retinal thickness by Fourier-domain optical coherence tomography and OCT retinal image analysis software segmentation analysis derived from Stratus optical coherence tomography images. J Biomed Opt (2011) 0.97

Macular thickness measurements in normal eyes with time-domain and Fourier-domain optical coherence tomography. Retina (2009) 0.96

Phenotypic characterization of a large family with RP10 autosomal-dominant retinitis pigmentosa: an Asp226Asn mutation in the IMPDH1 gene. Am J Ophthalmol (2005) 0.95

Trans-Tenon's retrobulbar injection of triamcinolone acetonide for diffuse diabetic macular edema. Jpn J Ophthalmol (2005) 0.93

The structure and function of the macula in patients with advanced retinitis pigmentosa. Invest Ophthalmol Vis Sci (2011) 0.90

[Optical coherence tomography for macular edema. Classification, quantitative assessment, and rational usage in the clinical practice]. Ophthalmologe (2004) 0.88

Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using intravitreal bevacizumab maintains functional visual acuity. Clin Ophthalmol (2012) 0.88

Cone structure in patients with usher syndrome type III and mutations in the Clarin 1 gene. JAMA Ophthalmol (2013) 0.87

[Central serous chorioretinopathy--retinal function and morphology: microperimetry and optical coherence tomography]. Ophthalmologe (2006) 0.84

Normative spectral domain optical coherence tomography data on macular and retinal nerve fiber layer thickness in Indians. Indian J Ophthalmol (2014) 0.83

A reference standard for the measurement of macular oedema. Br J Ophthalmol (2006) 0.81

Influence of diabetes on macular thickness measured using optical coherence tomography: the Singapore Indian Eye Study. Eye (Lond) (2012) 0.80

Ocular manifestations of Type 1 diabetes mellitus in pediatric population. Indian J Ophthalmol (2016) 0.75

Macular thickness and macular volume measurements using spectral domain optical coherence tomography in normal Nepalese eyes. Clin Ophthalmol (2016) 0.75

Evaluation of Central Macular Thickness and Retinal Nerve Fiber Layer Thickness using Spectral Domain Optical Coherence Tomography in a Tertiary Care Hospital. J Curr Glaucoma Pract (2014) 0.75

Correlation of retinal nerve fibre layer and macular thickness with serum uric acid among type 2 diabetes mellitus. BMC Ophthalmol (2017) 0.75

Normative database for separate inner retinal layers thickness using spectral domain optical coherence tomography in Caucasian population. PLoS One (2017) 0.75

Influence of macular oedema on the measurement of macular pigment optical density. Graefes Arch Clin Exp Ophthalmol (2015) 0.75

New algorithm to analyze optical coherence tomographic images quantitatively. Jpn J Ophthalmol (2008) 0.75

Articles by these authors

Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol (2001) 3.11

Macular hole formation: new data provided by optical coherence tomography. Arch Ophthalmol (1999) 2.87

Optical coherence tomography of idiopathic macular epiretinal membranes before and after surgery. Am J Ophthalmol (2000) 2.38

Effect of autologous platelet concentrate in surgery for idiopathic macular hole: results of a multicenter, double-masked, randomized trial. Platelets in Macular Hole Surgery Group. Ophthalmology (1999) 2.16

Foveal pseudocyst as the first step in macular hole formation: a prospective study by optical coherence tomography. Ophthalmology (2001) 2.00

Macular serous retinal detachment caused by subretinal leakage in tilted disc syndrome. Ophthalmology (1998) 2.00

Macular full-thickness and lamellar holes in association with type 2 idiopathic macular telangiectasia. Eye (Lond) (2008) 1.96

Evaluation of a new non-mydriatic digital camera for detection of diabetic retinopathy. Diabet Med (2003) 1.84

Maternally inherited diabetes and deafness: a multicenter study. Ann Intern Med (2001) 1.75

Benefits of Ophdiat, a telemedical network to screen for diabetic retinopathy: a retrospective study in five reference hospital centres. Diabetes Metab (2009) 1.56

Dissociated optic nerve fiber layer appearance of the fundus after idiopathic epiretinal membrane removal. Ophthalmology (2001) 1.51

Hereditary infantile hemiparesis, retinal arteriolar tortuosity, and leukoencephalopathy. Neurology (2003) 1.50

Sclerochoroidal calcification associated with Gitelman syndrome. Am J Ophthalmol (1999) 1.38

OPHDIAT: a telemedical network screening system for diabetic retinopathy in the Ile-de-France. Diabetes Metab (2008) 1.30

Comparison of optical coherence tomography models OCT1 and Stratus OCT for macular retinal thickness measurement. Br J Ophthalmol (2005) 1.14

Prevalence of macular pattern dystrophy in maternally inherited diabetes and deafness. GEDIAM Group. Ophthalmology (1999) 1.14

Relationship between macular hole size and the potential benefit of internal limiting membrane peeling. Br J Ophthalmol (2006) 1.10

Long-term incidence of reopening of macular holes. Ophthalmology (2000) 1.10

Autologous platelet concentrate for the treatment of full-thickness macular holes. Graefes Arch Clin Exp Ophthalmol (1995) 1.09

Acute transient myopia induced by indapamide. Am J Ophthalmol (2000) 1.09

Retinal abnormalities in CADASIL: a retrospective study of 18 patients. J Neurol Neurosurg Psychiatry (2004) 1.04

Late reopening of successfully treated macular holes. Br J Ophthalmol (1997) 1.00

[Central serous chorioretinopathy and systemic steroid therapy]. J Fr Ophtalmol (2001) 0.97

[Efficacy and efficiency of preoperative mydriasis: drops versus ocular insert]. J Fr Ophtalmol (2006) 0.97

Choroidal ischemia. Am J Ophthalmol (1982) 0.96

Prevalence of diabetic retinopathy in children and adolescents with type-1 diabetes attending summer camps in France. Diabetes Metab (2007) 0.96

Elicited repetitive daily blindness: a new phenotype associated with hemiplegic migraine and SCN1A mutations. Neurology (2009) 0.93

[Surgical treatment of post-traumatic macular holes]. J Fr Ophtalmol (1997) 0.93

Visual field loss after vitrectomy for full-thickness macular holes. Am J Ophthalmol (1997) 0.93

Macular pattern dystrophy associated with a mutation of mitochondrial DNA. Am J Ophthalmol (1995) 0.92

Macular traction detachment and diabetic edema associated with posterior hyaloidal traction. Am J Ophthalmol (2001) 0.92

Immunological study of acidic fibroblast growth factor (aFGF) distribution in the eye. J Cell Biochem (1989) 0.91

Growth factors and diabetic retinopathy. Diabetes Metab (1997) 0.90

Evaluation of fluorescein-labeled autologous leukocytes for examination of retinal circulation in humans. Curr Eye Res (2000) 0.90

Heterogeneity of diabetes phenotype in patients with 3243 bp mutation of mitochondrial DNA (Maternally Inherited Diabetes and Deafness or MIDD). Diabetes Metab (2004) 0.90

Evaluation of the effect of JPEG and JPEG2000 image compression on the detection of diabetic retinopathy. Eye (Lond) (2006) 0.89

Analysis of retinal and choroidal circulation during central retinal vein occlusion using indocyanine green videoangiography. Arch Ophthalmol (2001) 0.89

[Bouchut tubercles and AIDS. Apropos of 3 cases]. J Fr Ophtalmol (1994) 0.88

[Recommendations of the ALFEDIAM (French Association for the Study of Diabetes and Metabolic Diseases) for the screening and surveillance of diabetic retinopathy]. J Fr Ophtalmol (1997) 0.88

[Neuro-ophthalmologic initial presentation of sarcoidosis]. J Fr Ophtalmol (2006) 0.87

Screening for diabetic retinopathy: the first telemedical approach in a primary care setting in France. Diabetes Metab (2004) 0.86

[Changes in the fundus in subacute sclerosing panencephalitis. Apropos of 23 cases]. J Fr Ophtalmol (1992) 0.85

Subretinal electrode implantation in the P23H rat for chronic stimulations. Br J Ophthalmol (2006) 0.84

Evaluation of automated fundus photograph analysis algorithms for detecting microaneurysms, haemorrhages and exudates, and of a computer-assisted diagnostic system for grading diabetic retinopathy. Diabetes Metab (2010) 0.84

Acute posterior multifocal placoid pigment epitheliopathy after hepatitis B vaccine. Arch Ophthalmol (1995) 0.84

Visual outcome of surgery for epiretinal membranes with macular pseudoholes. Ophthalmology (1999) 0.84

Ocular fluorophotometric and angiographic findings in toxemia of pregnancy. Arch Ophthalmol (1986) 0.83

Functional assessment of macular hole surgery by scanning laser ophthalmoscopy. Ophthalmology (1998) 0.83

Evaluation of a screening program for diabetic retinopathy in a primary care setting Dodia (Dépistage ophtalmologique du diabète) study. Diabetes Metab (2005) 0.83

[Review of ophthalmologic complications in hereditary bullous epidermolysis. Apropos of 40 cases]. J Fr Ophtalmol (1999) 0.82

[Choriocapillaris occlusion in Moschowitz's disease (author's transl)]. J Fr Ophtalmol (1981) 0.82

Ophdiat(®): five-year experience of a telemedical screening programme for diabetic retinopathy in Paris and the surrounding area. Diabetes Metab (2012) 0.82

[Occlusion of the central retinal vein with occlusion of a cilioretinal artery: apropos of 7 cases]. J Fr Ophtalmol (1987) 0.82

Use of autologous platelet concentrate in macular hole surgery: report of 77 cases. Dev Ophthalmol (1997) 0.82

[Ablation of the internal limiting membrane, macular unfolding and visual outcome in surgery of idiopathic epimacular membranes]. J Fr Ophtalmol (1993) 0.82

[Current uses and indications for indocyanine green angiography]. J Fr Ophtalmol (2011) 0.81

[Retinectomies in the treatment of retinal detachments with vitreoretinal proliferation]. J Fr Ophtalmol (1997) 0.81

Retinal ischaemia in type 1 neurofibromatosis. Br J Ophthalmol (2006) 0.81

A hereditary moyamoya syndrome with multisystemic manifestations. Neurology (2010) 0.81

Natural course of nonaphakic cystoid macular edema. Surv Ophthalmol (1984) 0.80

Contribution of scanning laser ophthalmoscopy to the functional investigation of subjects with macular holes. Doc Ophthalmol (1994) 0.80

Spontaneous resolution of small stage 3 and 4 full-thickness macular holes viewed by optical coherence tomography. Retina (2001) 0.80

Macular pattern dystrophy in MIDD: long-term follow-up. Diabetes Metab (2008) 0.80

Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion. Br J Ophthalmol (2000) 0.79

Idiopathic intracranial hypertension: a comparison between French and North-American white patients. Rev Neurol (Paris) (2009) 0.79

[Treatment with argon laser photocoagulation in occlusions of the retinal venous branches. Indications, technic, results]. Bull Soc Ophtalmol Fr (1977) 0.79

Systolodiastolic variations of blood flow during central retinal vein occlusion: exploration by dynamic angiography. Br J Ophthalmol (2005) 0.78

Scanning laser ophthalmoscope imaging of fluorescein-labelled blood cells. Graefes Arch Clin Exp Ophthalmol (1997) 0.78

Epiretinal membranes surrounding idiopathic macular holes. Retina (1998) 0.78

[A new grading system from color fundus photographs for screening for diabetic retinopathy]. J Fr Ophtalmol (2007) 0.78

[Value of local ophthalmic artery fibrinolysis in severe forms of central retinal vein occlusion]. J Radiol (2001) 0.78

Indocyanine green angiography in choroidal osteoma. Graefes Arch Clin Exp Ophthalmol (1997) 0.78

Familial central retinal vein occlusion. Eye (Lond) (2006) 0.78

[Retinopathy in pancreatitis]. J Fr Ophtalmol (1989) 0.78